PPARGC1A and Alzheimer disease: A new approach for the treatment of AD based on the preservation of the mitochondrial structure as a target (Course and Wang, 2016; Arrazola et al., 2017) opens a new line of study, and according with our data PGC1-α could be a interesting candidate.